Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
LetterOnline Letters: Comments and Responses
Open Access

International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy

Response to Weinert

Boyd E. Metzger, Steven G. Gabbe, Bengt Persson, Lynn P. Lowe, Alan R. Dyer, Jeremy J.N. Oats, Thomas A. Buchanan
DOI: 10.2337/dc10-0719 Published 1 July 2010
Boyd E. Metzger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
  • For correspondence: bem@northwestern.edu
Steven G. Gabbe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Bengt Persson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Lynn P. Lowe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Alan R. Dyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Jeremy J.N. Oats
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Thomas A. Buchanan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site

In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort.

The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some outcomes, but did not define diagnostic thresholds as suggested by Weinert. Due to space limitations, this study was not cited in the IADPSG report (3). However, at the June 2008 IADPSG International Workshop Conference on Gestational Diabetes Diagnosis and Classification in Pasadena, California, Dr. Maria Ines-Schmidt, principal investigator of the Brazilian study, presented an unpublished analysis of associations of maternal fasting plasma glucose and 75-g 1-h and 2-h postload glucose with perinatal outcomes. Although the study sample size was not nearly as large as that of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, associations tended to be similar (4).

Weinert also focuses on the fact that the IADPSG recommended criteria diagnose a greater proportion as GDM than other criteria. The major reason for this is that the IADPSG diagnosis of GDM only requires that one or more values meets or exceeds a threshold; most other strategies require at least two abnormal values for the diagnosis. In addition, as noted in the IADPSG report (3), relatively small changes in glucose thresholds, especially for fasting plasma glucose, result in large differences in proportions diagnosed as GDM.

Weinert states that in the analysis of Brazilian results, 1-h and 2-h 75-g oral glucose tolerance test values “virtually overlapped for predicting fetal macrosomia and composite outcome.” This is offered in support of a shorter 1-h test. As Weinert indicated, FPG and 1-h thresholds identified a large majority of GDM women in the HAPO study cohort. However, as indicated in the IADPSG report (3), the 2-h threshold identified a small proportion of women not detected by fasting and 1-h thresholds who were at increased risk of adverse outcomes.

The primary focus of the IADPSG Consensus Panel was to recommend diagnostic threshold values that identified clinically significant risk for adverse pregnancy outcome. We feel that goal was achieved with the strategy for detection and diagnosis of GDM that was recommended.

Acknowledgments

No potential conflicts of interest relevant to this article were reported.

B.E.M. contributed to the discussion, wrote the manuscript, and reviewed/edited the manuscript. S.G.G. reviewed/edited the manuscript. B.P. reviewed/edited the manuscript. L.P.L. wrote the manuscript and reviewed/edited the manuscript. A.R.D. reviewed/edited the manuscript. J.J.N.O. reviewed/edited the manuscript. T.A.B. reviewed/edited the manuscript.

  • © 2010 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

    1. Weinert LS
    : International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel (Letter). Diabetes Care 2010; 33: e97. DOI: 10.2337/dc10-0544
    1. Schmidt MI,
    2. Duncan BB,
    3. Reichelt AJ,
    4. Branchtein L,
    5. Matos MC,
    6. Costa e Forti A,
    7. Spichler ER,
    8. Pousada JM,
    9. Teixeira MM,
    10. Yamashita T
    for the Brazilian Gestational Diabetes Study Group. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 2001; 24: 1151–1155
  1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676–682
    1. HAPO Study Cooperative Research Group,
    2. Metzger BE,
    3. Lowe LP,
    4. Dyer AR,
    5. Trimble ER,
    6. Chaovarindr U,
    7. Coustan DR,
    8. Hadden DR,
    9. McCance DR,
    10. Hod M,
    11. McIntyre HD,
    12. Oats JJ,
    13. Persson B,
    14. Rogers MS,
    15. Sacks DA
    : Hyperglycemia and adverse pregnancy outcomes. NEJM 2008; 358: 1991–2002

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.